Companion Diagnostics Market

Companion Diagnostics Market (Indication Type - Breast Cancer, Lung Cancer, Colorectal Cancer, Gastric Cancer, Melanoma, Thalassemia, and HIV) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2011 - 2019

  • Rep Id : TMRGL387
  • Published On : Aug 2013
  • No. of Pages : 89
  • Category : Healthcare

Table of contents

 

Chapter 1 Introduction

1.1 Report Description

1.2 Market Segmentation

1.3 Research Methodology

1.4 List of Abbreviations

 

Chapter 2 Executive Summary

 

Chapter 3 Market Overview

3.1 Introduction

3.2 Market Drivers

      3.2.1 Regulatory changes: The need for development of CDx along with targeted therapies

      3.2.2 Increasing demand as well as developmental efforts towards personalized medicine

      3.2.3 The pharmacoeconomic advantage: Reduced drug development costs

      3.2.4 Increasing cancer incidence worldwide

      3.2.5 Impact Analysis of Market Drivers

3.3 Market Restraints

      3.3.1 Effect of influence of advocacy groups and clinical societies

      3.3.2 Prolonged developmental and approval phases

      3.3.3 Reimbursement scenario

      3.3.4 Impact Analysis of Market Restraints

3.4 Market Opportunity

      3.4.1 Expansion into newer indication areas

3.5 Porter’s Five Forces Analysis: Global Companion Diagnostics Market

      3.5.1 Bargaining Power of Suppliers

      3.5.2 Bargaining Power of Buyers

      3.5.3 Threat of Substitutes

      3.5.4 Threat of New Entrants

      3.5.5 Competitive Rivalry

3.6 Market Attractiveness Analysis: Global Companion Diagnostics Market, by Geography, 2012

 

Chapter 4 Companion Diagnostics Market, by Indication, 2011 - 2019 (USD Million)

4.1 Introduction

      4.1.1 Comparative Analysis: Global Companion Diagnostics Market, by Indication, 2012 & 2019 (Value %)

      4.1.2 Breast Cancer

               4.1.2.1 Global Breast Cancer Companion Diagnostics Market, Size and Forecast, 2011 - 2019 (USD Million)

      4.1.3 Lung Cancer

              4.1.3.1 Global Lung Cancer Companion Diagnostics Market, Size and Forecast, 2011 - 2019 (USD Million)

      4.1.4 Colorectal Cancer

               4.1.4.1 Global Colorectal Cancer Companion Diagnostics Market, Size and Forecast, 2011 - 2019 (USD Million)

      4.1.5 Gastric Cancer

               4.1.5.1 Global Gastric Cancer Companion Diagnostics Market, Size and Forecast, 2011 - 2019 (USD Million)

      4.1.6 Melanoma

              4.1.6.1 Global Melanoma Companion Diagnostics Market, Size and Forecast, 2011 - 2019 (USD Million)

      4.1.7 Others (HIV, Thalassemia)

               4.1.7.1 Global Other Companion Diagnostics Market, Size and Forecast, 2011 - 2019 (USD Million)

 

Chapter 5 Companion Diagnostics Market, by Geography, 2011 - 2019 (USD Million)

5.1 Overview

      5.1.1 Comparative Analysis: Global Companion Diagnostics Market by Geography, 2012 & 2019 (Value %)

5.2 North America

      5.2.1 North America Companion Diagnostics Market, Size and Forecast, 2011 - 2019 (USD Million)

5.3 Europe

      5.3.1 Europe Companion Diagnostics Market, Size and Forecast, 2011 - 2019 (USD Million)

5.4 Asia-Pacific

      5.4.1 Asia-Pacific Companion Diagnostics Market, Size and Forecast, 2011 - 2019 (USD Million)

5.5 Rest of the World (RoW)

      5.5.1 RoW Companion Diagnostics Market, Size and Forecast 2011 - 2019  (USD Million)

 

Chapter 6 Competitive Landscape

6.1 Market Share by Key Players, 2012 (%)

 

Chapter 7 Recommendations

7.1 Adoption of newer business models enabling co-developing companion diagnostics

7.2 Focus on research-intense investments

 

Chapter 8 Company Profiles

8.1 Abbott Laboratories

      8.1.1 Company Overview

      8.1.2 Financial Overview

      8.1.3 Product Portfolio

      8.1.4 Business Strategies

      8.1.5 Recent Developments

               8.1.5.1 FDA Approval

8.2 Agendia N.V.

      8.2.1 Company Overview

      8.2.2 Product Portfolio

      8.2.3 Business Strategies

      8.2.4 Recent Developments

8.3 Agilent Technologies, Inc.

      8.3.1 Company Overview

      8.3.2 Financial Overview

      8.3.3 Product Portfolio

      8.3.4 Business Strategies

      8.3.5 Recent Developments

8.4 BioGenex Laboratories Inc.

      8.4.1 Company Overview

      8.4.2 Product Portfolio

      8.4.3 Business Strategies

      8.4.4 Recent Developments

8.5 bioMérieux SA

      8.5.1 Company Overview

      8.5.2 Financial Overview

      8.5.3 Product Portfolio

      8.5.4 Business Strategies

      8.5.5 Recent Developments

8.6 GE Healthcare Ltd.

      8.6.1 Company Overview

      8.6.2 Financial Overview

      8.6.3 Product Portfolio

      8.6.4 Business Strategies

      8.6.5 Recent Developments

8.7 Genomic Health, Inc.

      8.7.1 Company Overview

      8.7.2 Financial Overview

      8.7.3 Product Portfolio

      8.7.4 Business Strategies

      8.7.5 Recent Developments

8.8 Life Technologies Corporation

      8.8.1 Company Overview

      8.8.2 Financial Overview

      8.8.3 Product Portfolio

      8.8.4 Business Strategies

      8.8.5 Recent Developments

8.9 Qiagen N.V.

      8.9.1 Company Overview

      8.9.2 Financial Overview

      8.9.3 Product Portfolio

      8.9.4 Business Strategies

      8.9.5 Recent Developments

8.10 Resonance Health Analysis Services Pty Ltd.

      8.10.1 Company Overview

      8.10.2 Product Portfolio

      8.10.3 Business Strategies

      8.10.4 Recent Developments

8.11 Roche Holdings AG

      8.11.1 Company Overview

      8.11.2 Financial Overview

      8.11.3 Product Portfolio

      8.11.4 Business Strategies

      8.11.5 Recent Developments

8.12 Siemens Healthcare

      8.12.1 Company Overview

      8.12.2 Financial Overview

      8.12.3 Product Portfolio

      8.12.4 Business Strategies 

      8.12.5 Recent Developments

List of Tables

 

TABLE 1 List of Abbreviations

TABLE 2 Market Snapshot: Global Companion Diagnostics Market

TABLE 3 Cancer Incidence, by Type, 2008 and 2015 (Million)

TABLE 4 Impact Analysis of Market Drivers

TABLE 5 Impact Analysis of Market Restraints

TABLE 6 Companion Diagnostics Required or Recommended by the U.S. FDA

TABLE 7 Global Companion Diagnostics Market, by Indication, 2011 - 2019 (USD Million)

TABLE 8 Breast Cancer Companion Diagnostics (CDx), Manufacturers and Target Drugs

TABLE 9 Lung Cancer Companion Diagnostics (CDx), Manufacturers and Target Drugs

TABLE 10 Colorectal Cancer Companion Diagnostics (CDx), Manufacturers and Target Drugs

TABLE 11 Gastric Cancer Companion Diagnostics (CDx), Manufacturers and Target Drugs

TABLE 12 Melanoma Companion Diagnostics (CDx), Manufacturers and Target Drugs

TABLE 13 Other Companion Diagnostics (CDx), Indications and Manufacturers

TABLE 14 Global Companion Diagnostics Market, by Geography, Size and Forecast, 2011 - 2019 (USD Million)

 

List of Figures

 

FIG. 1 Companion Diagnostics Market Segmentation

FIG. 2 Global Companion Diagnostics Market, by Indication, 2012 (USD Million)

FIG. 3 Porter’s Five Forces Analysis: Global Companion Diagnostics Market

FIG. 4 Market Attractiveness Analysis: Global Companion Diagnostics Market, by Geography, 2012

FIG. 5 Comparative Analysis: Global Companion Diagnostics Market, by Indication, 2012 & 2019 (Value %)

FIG. 6 Global Breast Cancer Companion Diagnostics Market, Size and Forecast, 2011 - 2019 (USD Million)

FIG. 7 Global Lung Cancer Companion Diagnostics Market, Size and Forecast, 2011 - 2019 (USD Million)

FIG. 8 Global Colorectal Cancer Companion Diagnostics Market, Size and Forecast, 2011 - 2019 (USD Million)

FIG. 9 Global Gastric Cancer Companion Diagnostics Market, Size and Forecast, 2011 - 2019 (USD Million)

FIG. 10 Global Melanoma Companion Diagnostics Market, Size and Forecast, 2011 - 2019 (USD Million)

FIG. 11 Global Other Companion Diagnostics Market, Size and Forecast, 2011 - 2019 (USD Million)

FIG. 12 Comparative Analysis: Global Companion Diagnostics Market, by Geography, 2012 & 2019 (Value %)

FIG. 13 North America Companion Diagnostics Market, Size and Forecast, 2011 – 2019 (USD Million)

FIG. 14 Europe Companion Diagnostics Market, Size and Forecast, 2011 – 2019 (USD Million)

FIG. 15 Asia-Pacific Companion Diagnostics Market, Size and Forecast, 2011 – 2019 (USD Million)

FIG. 16 RoW Companion Diagnostics Market, Size and Forecast, 2011 - 2019 (USD Million)

FIG. 17 Market Share Analysis: Global Companion Diagnostics Market, 2012 (%)

FIG. 18 Annual Revenues: Abbott Laboratories, 2010 – 2012 (USD Million)

FIG. 19 Annual Revenue: Agilent Technologies, Inc., 2010 – 2012 (USD Million)

FIG. 20 Annual Revenues:  bioMérieux SA, 2010 – 2012 (USD Million)

FIG. 21 Annual Revenue: GE Healthcare Ltd., 2010 – 2012 (USD Million)

FIG. 22 Annual Revenues: Genomic Health Inc.,  2010 – 2012 (USD Million)

FIG. 23 Annual Revenues: Life Technologies Corporation, 2010 – 2012 (USD Million)

FIG. 24 Annual Sales: Qiagen N.V., 2010 – 2012 (USD Million)

FIG. 25 Annual Revenues: Roche Holdings AG, 2010 – 2012 (USD Million) (1 CHF = 1.09 USD)

FIG. 26 Annual Revenues: Siemens Healthcare, 2010 – 2012 (USD Million)

.